Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

Detalles Bibliográficos
Autores principales: Mehta, Puja, Rosas, Ivan O., Singer, Mervyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Understanding the Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453725/
https://www.ncbi.nlm.nih.gov/pubmed/36074167
http://dx.doi.org/10.1007/s00134-022-06877-w
_version_ 1784785201751130112
author Mehta, Puja
Rosas, Ivan O.
Singer, Mervyn
author_facet Mehta, Puja
Rosas, Ivan O.
Singer, Mervyn
author_sort Mehta, Puja
collection PubMed
description
format Online
Article
Text
id pubmed-9453725
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94537252022-09-08 Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity Mehta, Puja Rosas, Ivan O. Singer, Mervyn Intensive Care Med Understanding the Disease Springer Berlin Heidelberg 2022-09-08 2022 /pmc/articles/PMC9453725/ /pubmed/36074167 http://dx.doi.org/10.1007/s00134-022-06877-w Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Understanding the Disease
Mehta, Puja
Rosas, Ivan O.
Singer, Mervyn
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
title Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
title_full Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
title_fullStr Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
title_full_unstemmed Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
title_short Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
title_sort understanding post-covid-19 interstitial lung disease (ild): a new fibroinflammatory disease entity
topic Understanding the Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453725/
https://www.ncbi.nlm.nih.gov/pubmed/36074167
http://dx.doi.org/10.1007/s00134-022-06877-w
work_keys_str_mv AT mehtapuja understandingpostcovid19interstitiallungdiseaseildanewfibroinflammatorydiseaseentity
AT rosasivano understandingpostcovid19interstitiallungdiseaseildanewfibroinflammatorydiseaseentity
AT singermervyn understandingpostcovid19interstitiallungdiseaseildanewfibroinflammatorydiseaseentity

Ejemplares similares